V003-2537 Screening compound: 4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

V003-2537 Screening compound: 4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide
V003-2537 Screening compound: 4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-2537
4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-2537

Molecular Formula

C25H21F3N2O2S (C25 H21 F3 N2 O2 S)

Compound Name

4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)benzamide

IUPAC name

4-ethyl-N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-13-thiazolidin-2-yl}phenyl)benzamide

SMILES

CCc(cc1)ccc1C(Nc1cccc(C(N2c3ccc(C(F)(F)F)cc3)SCC2=O)c1)=O

InChI

InChI=1S/C25H21F3N2O2S/c1-2-16-6-8-17(9-7-16)23(32)29-20-5-3-4-18(14-20)24-30(22(31)15-33-24)21-12-10-19(11-13-21)25(26,27)28/h3-14,24H,2,15H2,1H3,(H,29,32)/t24-/m0/s1

InChI Key

ZLIREJFFFUXJBL-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD19860242

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.983

Distribution Coefficient, logD

5.983

Water Solubility, LogSw

-5.56

Polar Surface Area

39.224

Acid Dissociation Constant (pKa)

10.76

Base Dissociation Constant (pKb)

-1.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.00

V003-2537 in Drug Discovery

Included in Screening Libraries

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V003-2537 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-2537?
Check Price and Availability of V003-2537, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-2537 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-2537
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-2537
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-2537 available by request